Drug intelligence / Profile preview

progesterone + estradiol

Development stage
Unknown
Lead developer
Peter Humaidan
Modality
Small Molecules
Administration
Vaginal, Oral, Intramuscular, Transdermal
01

Overview

Progesterone + estradiol is a combination hormonal therapy used for luteal phase support (LPS) in assisted reproductive technology (ART), specifically In Vitro Fertilization (IVF). Progesterone is a steroid hormone essential for the secretory transformation of the endometrium, which is necessary for embryo implantation and the maintenance of early pregnancy. Estradiol is often co-administered to maintain serum estrogen levels during the luteal phase, particularly in protocols where endogenous production may be compromised by pituitary suppression or specific trigger agents. In the clinical research conducted by Peter Humaidan, this combination typically serves as the standard-of-care control treatment against which experimental protocols, such as GnRHa triggers followed by low-dose hCG support, are compared to evaluate pregnancy outcomes and the risk of ovarian hyperstimulation syndrome (OHSS).

Brand names
CrinoneEstrofem
Other names
Progesterone and EstradiolExogenous progesterone and estradiol support
02

Targets

GPER1 (G protein-coupled estrogen receptor 1)ESR2 (ERβ)PR (Progesterone receptor)ESR1 (ERα)

Beyond the preview

Go deeper on progesterone + estradiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on progesterone + estradiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call